A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01)
Patent
CA 2468499
The present invention provides a new subcutaneous injection dosing regimen for erythropoietin to treat anemia. The new erythropoietin treatment regimen of the present invention results in improved hemoglobin levels with less frequent dosing.
La présente invention concerne un nouveau schéma de dosage d'injection sous-cutanée d'érythropoïétine pour traiter l'anémie. Ledit nouveau schéma de traitement par érythropoïétine selon la présente invention permet d'obtenir des niveaux d'hémoglobine améliorés avec un dosage moins fréquent.
Farrell Francis
Ortho-Mcneil Pharmaceutical Inc.
Smart & Biggar
LandOfFree
Erythropoietin dosing regimen for treating anemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Erythropoietin dosing regimen for treating anemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin dosing regimen for treating anemia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1582890